Search Clinical Trials
589,087 trials
ID
Status
Phase
Title
Sponsor
NCT07645807
An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evaluate the Adjunctive Effect of CreNeuroS™ CNS Fish Oil Plus Softgels in Patients With Major Depressive Disorder Receiving Escitalopram.Sichuan Credit Pharmaceutical Co., Ltd.Not Yet RecruitingNot Applicable
NCT07645807Not Yet Recruiting
Not Applicable
An Investigator-Initiated, Randomized, Double-Blind, Double-Dummy Study to Evalu...Sichuan Credit Pharmaceut...
NCT07644260
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric PatientsHospital de Clinicas José de San MartínNot Yet Recruiting
NCT07644260Not Yet Recruiting
—
Transition From Sevoflurane to Total Intravenous Anesthesia in Pediatric Patient...Hospital de Clinicas José...
NCT07645846
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital, Sun Yat-Sen UniversityNot Yet RecruitingPhase 2
NCT07645846Not Yet Recruiting
Phase 2
Neoadjuvant Docetaxel, Cisplatin, and Dual Immunotherapy for Sinonasal CarcinomaFirst Affiliated Hospital...
NCT07645222
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D CompanyNot Yet RecruitingPhase 1
NCT07645222Not Yet Recruiting
Phase 1
PHASE 1b STUDY OF HS-20122 COMBINED THERAPY IN NSCLCHansoh BioMedical R&D Com...
NCT07646353
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy AdultsGlaxoSmithKlineNot Yet RecruitingPhase 1
NCT07646353Not Yet Recruiting
Phase 1
First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in H...GlaxoSmithKline
NCT07644351
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lymphoblastic Leukemia PatientsNovartis PharmaceuticalsCompleted
NCT07644351Completed
—
A Real-world Study of Asciminib Effectiveness in Philadelphia Positive Acute Lym...Novartis Pharmaceuticals
NCT07644390
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal Surgery Using Longitudinal Indices of Routine Blood Tests: A Single-Center Retrospective Cohort StudySixth Affiliated Hospital, Sun Yat-sen UniversityCompleted
NCT07644390Completed
—
Development of a Dynamic Prediction Model for Crohn's Disease-Related Intestinal...Sixth Affiliated Hospital...
NCT07643792
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture SurgeryPeking University First HospitalNot Yet RecruitingPhase 4
NCT07643792Not Yet Recruiting
Phase 4
Fascia Iliaca Block Using Liposomal Bupivacaine for Analgesia After Hip Fracture...Peking University First H...
NCT07646275
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy LossHarran UniversityCompletedNot Applicable
NCT07646275Completed
Not Applicable
Surgical vs. Medical Abortion on Sexual Function After Early Pregnancy LossHarran University
NCT07644741
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal PlayersFederal University of VicosaCompletedNot Applicable
NCT07644741Completed
Not Applicable
Load-Matched Unilateral Versus Bilateral Squat Training in Elite Youth Futsal Pl...Federal University of Vic...
NCT07644780
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Maternal Multiple Micronutrients SupplementsNutrition InternationalCompletedNot Applicable
NCT07644780Completed
Not Applicable
Evaluation of an Intervention for Optimizing Pregnant Women's Adherence to Mater...Nutrition International
NCT07644754
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level (PSA) Remains >0,2 ng/ml After Six Months of Dual Antihormonal Therapy Will Receive Radiotherapy to the Prostate and Radiotherapy to Refractory MetastasesLudwig-Maximilians - University of MunichNot Yet RecruitingNot Applicable
NCT07644754Not Yet Recruiting
Not Applicable
Patients With Metastasized Prostate Cancer Whose Prostate-specific Antigen-level...Ludwig-Maximilians - Univ...
NCT07645651
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectable, or Locally Advanced Basal Pancreatic CancerCarrick Therapeutics LimitedNot Yet RecruitingPhase 1
NCT07645651Not Yet Recruiting
Phase 1
Samuraciclib for the Treatment of Patients With Resectable, Borderline Resectabl...Carrick Therapeutics Limi...
NCT07645027
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patient With Cervical Spinal Cord InjuriesRiphah International UniversityRecruitingNot Applicable
NCT07645027Recruiting
Not Applicable
Low Volume Nose Resistance Breathing Exercise With Incentive Spirometer in Patie...Riphah International Univ...
NCT07645664
Scar Management Through Serial CastingCentre hospitalier de l'Université de Montréal (CHUM)Not Yet RecruitingNot Applicable
NCT07645664Not Yet Recruiting
Not Applicable
Scar Management Through Serial CastingCentre hospitalier de l'U...
NCT07644897
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients With Advanced MelanomaSun Yat-sen UniversityRecruitingPhase 2
NCT07644897Recruiting
Phase 2
Thymosin Alpha 1 Combined With Anti-PD-1 Monoclonal Antibody in Elderly Patients...Sun Yat-sen University
NCT07644767
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty LtdNot Yet RecruitingPhase 2
NCT07644767Not Yet Recruiting
Phase 2
Adjunctive Oral KET-AD Capsules in Treatment Resistant Bipolar DepressionNeurocentrx Pharma Pty Lt...
NCT07645066
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients With Sinus Node DysfunctionShanghai Tong Ren HospitalNot Yet RecruitingNot Applicable
NCT07645066Not Yet Recruiting
Not Applicable
Posterosuperior Bundle Pacing for Prevention of Atrial Fibrillation in Patients...Shanghai Tong Ren Hospita...
NCT07644871
A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4% Hydroquinone in Women With Mild to Severe Full-face HyperpigmentationRevision SkincareCompletedNot Applicable
NCT07644871Completed
Not Applicable
A 4-week Study Investigating Two Targeted Brightening Serum (A and B) Versus 4%...Revision Skincare
Result Breakdown
Not yet recruiting11 (55%)
Completed7 (35%)
Recruiting2 (10%)
not_applicable9 (45%)
Phase 14 (20%)
Not Specified3 (15%)
Phase 23 (15%)
Phase 41 (5%)